RMRodrigo Bronze de Martino

Rodrigo Bronze de Martino

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rodrigo Bronze de Martino has a total of 82 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Incidence of intra-abdominal hypertension after liver transplantation with temporary portocaval shunt – A prospective cohort

    by Estrella Bianca Melo, Luiz Augusto Carneiro-D’ALbuquerque, Wellington Andraus, Rodolpho Augusto Pedro, Bruna Carla Scharank, Paula Sepulveda Mesquita, Daniel Reis Waisberg, Rodrigo Bronze de Martino, Vinicius Rocha-Santos, Liliana Ducatti, et al.

  • Open Access

    Experimental model of small-for-size syndrome in pigs

    by Paola Sofia Espinoza Alvarez, Jhosimar Alvarez DE Lá Hoz, Daniel Reis Waisberg, Alessandro Rodrigo Belon, Larissa Barbosa Lima, Beatriz de Lima Soares, Ricardo Luis Santamaria Gonzalez, Rubens Macedo Arantes, João Paulo Costa dos Santos, Pedro Carvalho Cassino, et al.

    Background: Small-for-size syndrome (SFSS) is a serious complication after partial liver transplantation or extended hepatectomy. Despite advances, the syndrome remains a complex entity with a multifactorial pathophysiology and a lack of standardized therapeutic approaches. Aims: This study aims to establish a translational model of porcine SFSS, integrating hemodynamic, histopathological, and molecular analyses to quantify the tissue expression of biomarkers to assess liver regeneration. Methods: Ten liver transplants were performed: eight with small (partial) for size (donors underwent a 70% hepatectomy) and two with whole liver. The recipients were followed until death (euthanasia due to severe morbidity) or for five days. Hemodynamic data, laboratory analyses, and liver tissue biopsies were collected. Immunohistochemistry was performed to assess the expression of TNF-α, IL-1β, NF-κB, and VEGF. Gene expression levels of VEGF, IL-6, IL-10, and NF-κB were quantified using reverse transcription polymerase chain reaction. Results: In the partial group, survival rates were 75% in the immediate postoperative period, 25% at 48 hours, and 12.5% at five days. Immunohistochemistry showed a significant increase in TNF-α and NF-κB proteins after reperfusion and at the end of surgery, respectively. Gene expression analysis showed a significant increase in IL-6 and IL-10 at the end of surgery. Conclusions: This study represents a methodological advance by performing the first integrated evaluation of protein and gene expression (TNF-α, IL-6, IL-1, IL-10, VEGF, and NF-κB) correlated with hemodynamic, histopathological, and functional parameters in the small-for-size pig model.

  • Open Access

    Uterus transplantation — indications, technique, and results

    by Wellington Andraus, Dani Ejsenberg, Daniel Reis Waisberg, Alexandre Chagas Santana, Liliana Ducatti, Rubens Macedo Arantes, Rodrigo Bronze de Martino, Vinicius Rocha Santos, Rafael Soares Pinheiro, Luciana Leis, et al.

    Uterus transplantation was a transformative innovation in reproductive medicine and organ transplantation in general, and an alternative for the treatment of infertility. The problem of infertility affects 8–12% of the population of reproductive age, causing an enormous social impact. Uterus transplantation, a relatively new treatment, has emerged as an excellent option for couples with absolute uterine infertility. The first uterus transplant performed was in 2000, in Saudi Arabia. At this same time, a Swedish researcher began several experimental works with uterine transplantation in different animal models. Only more than a decade after the first attempt in humans was a second case performed, in Turkey, in 2011. The first transplant in the Americas was performed in the United States of America, in 2016, with a deceased donor. In the same year, in Brazil, the group from Hospital das Clínicas, Faculty of Medicine, University of São Paulo, performed the first uterus transplant in Latin America, also with a deceased donor. This Brazilian case resulted in the world’s first birth from a deceased donor uterus transplant in December 2017, making Brazil and Hospital das Clínicas in a vanguard position in the world transplant scenario. Even so, we have today more than 100 transplants performed on the planet, with the birth of more than 70 children.


  • Open Access

    Molecular Profile of Intrahepatic Cholangiocarcinoma

    by Wellington Andraus, Francisco Tustumi, José Donizeti de Meira Junior, Rafael Soares Nunes Pinheiro, Daniel Reis Waisberg, Liliana Ducatti Lopes, Rubens Macedo Arantes, Vinicius Rocha Santos, Rodrigo Bronze de Martino, Luiz Augusto Carneiro D’albuquerque

    Intrahepatic cholangiocarcinoma (ICC) is a relatively uncommon but highly aggressive primary liver cancer that originates within the liver. The aim of this study is to review the molecular profile of intrahepatic cholangiocarcinoma and its implications for prognostication and decision-making. This comprehensive characterization of ICC tumors sheds light on the disease’s underlying biology and offers a foundation for more personalized treatment strategies. This is a narrative review of the prognostic and therapeutic role of the molecular profile of ICC. Knowing the molecular profile of tumors helps determine prognosis and support certain target therapies. The molecular panel in ICC helps to select patients for specific therapies, predict treatment responses, and monitor treatment responses. Precision medicine in ICC can promote improvement in prognosis and reduce unnecessary toxicity and might have a significant role in the management of ICC in the following years. The main mutations in ICC are in tumor protein p53 (TP53), Kirsten rat sarcoma virus (KRAS), isocitrate dehydrogenase 1 (IDH1), and AT-rich interactive domain-containing protein 1A (ARID1A). The rate of mutations varies significantly for each population. Targeting TP53 and KRAS is challenging due to the natural characteristics of these genes. Different stages of clinical studies have shown encouraging results with inhibitors of mutated IDH1 and target therapy for ARID1A downstream effectors. Fibroblast growth factor receptor 2 (FGFR2) fusions are an important target in patients with ICC. Immune checkpoint blockade can be applied to a small percentage of ICC patients. Molecular profiling in ICC represents a groundbreaking approach to understanding and managing this complex liver cancer. As our comprehension of ICC’s molecular intricacies continues to expand, so does the potential for offering patients more precise and effective treatments. The integration of molecular profiling into clinical practice signifies the dawn of a new era in ICC care, emphasizing personalized medicine in the ongoing battle against this malignancy.


  • Open Access

    Attitude and knowledge of medical students toward donation after circulatory death

    by Rodrigo Bronze de Martino, Diogo Visconti Guidotte, Daniel Reis Waisberg, Alexandre Guerra dos Santos, Alex Jones Flores Cassenote, Rubens Macedo Arantes, Luciana Bertocco Haddad, Flavio Henrique Galvão, Luiz Augusto Carneiro-D’aLbuquerque

    OBJECTIVE: A survey among medical students in a Brazilian public university was performed to investigate the acceptance of organ donation in Brazil, particularly donation after circulatory death (DCD). METHODS: A questionnaire including 26 objectives and Likert scale questions was validated and sent to all medical students of our institution. The answers were analyzed considering the whole set of individuals as well as by dividing the medical students into two groups: less graduated students and more graduated students. RESULTS: From 1050 students, 103 spontaneous answers (9.8%) were retrieved after 3 weeks. A total of 89.3% agreed totally with deceased donor organ donation and 8.7% agreed partially. However, only 50.5% of the students agreed totally and 31.1% agreed partially to living donation. Students revealed that 82.6% know the concept of brain death. On the other hand, 71.8% of them declared not knowing the concept of planned withdrawal of life-sustaining therapy, mainly cardiorespiratory support. A total of 85.4% of students agreed totally with donation after brain death and 11.7% agreed partially. However, when questioned about donation in awaiting circulatory death after a planned withdrawal of life-sustaining therapy, only 18.4% agreed totally and 32% agreed partially. Both groups of less and more graduated students showed similar results. CONCLUSIONS: Our study found a clear lack of information and consequently in acceptance of DCD. Education in the field of end-oflife management may improve not only the acceptance of DCD donation but also the whole understanding of planned withdrawal of life-sustaining therapy.


  • Open Access

    PROTOCOLO DE TRANSPLANTE HEPÁTICO PARA METÁSTASE COLORRETAL IRRESSECÁVEL

    by Lucas Ernani, Eduardo de Souza Martins Fernandes, Rodrigo Bronze de Martino, Fabricio Ferreira Coelho, Felipe Pedreira Tavares de Mello, Ronaldo Andrade, Leandro Savattone Pimentel, Luciana Bertocco de Paiva Haddad, Paulo Herman, Wellington Andraus, et al.

    RESUMO - RACIONAL: O câncer colorretal é a terceira neoplasia mais frequente e metade dos pacientes desenvolvem metástase hepática. O melhor fator prognóstico na metástase hepática de câncer colorretal (MHCCR) é a possibilidade de ressecção com margens livres, porém a maioria permanece irressecável. O racional em realizar transplante hepático (TH) em pacientes portadores de MHCCR está na ampliação do número de pacientes ressecáveis através de uma hepatectomia total. OBJETIVO: Apresentar protocolo brasileiro para realização de transplante hepático em pacientes com MHCCR irressecável. MÉTODO: O protocolo foi realizado por duas instituições com grande volume de ressecções e transplantes hepáticos no Brasil, baseado no trabalho realizado pela Universidade de Oslo. A elaboração foi dividida em 4 etapas. RESULTADO: É apresentada proposta de protocolo para esta doença a ser validada na aplicação clínica. CONCLUSÃO: Foi possível elaborar protocolo de transplante hepático para MHCCR irressecável a fim de uniformizar o tratamento e melhor avaliar os resultados cirúrgicos.


  • Open Access

    CIRRHOTIC PATIENTS WITH ACUTE KIDNEY INJURY (AKI) HAVE HIGHER MORTALITY AFTER ABDOMINAL HERNIA SURGERY

    by Liliana Ducatti, Luciana B. P. Haddad, Alberto Meyer, Lucas S. Nacif, Rubens M. Arantes, Rodrigo B. Martino, Vinicius Rocha-Santos, Daniel R. Waisberg, Rafael S. Pinheiro, Luiz A.C. D´aLbuquerque, et al.

    Background: The incidence of abdominal hernia in cirrhotic patients is as higher as 20%; in cases of major ascites the incidence may increase up to 40%. One of the main and most serious complications in cirrhotic postoperative period (PO) is acute kidney injury (AKI). Aim: To analyze the renal function of cirrhotic patients undergoing to hernia surgery and evaluate the factors related to AKI. Methods: Follow-up of 174 cirrhotic patients who underwent hernia surgery. Laboratory tests including the renal function were collected in the PO.AKI was defined based on the consensus of the ascite´s club. They were divided into two groups: with (AKI PO) and without AKI . Results: All 174 patients were enrolled and AKI occurred in 58 (34.9%). In the AKI PO group, 74.1% had emergency surgery, whereas in the group without AKI PO it was only 34.6%.In the group with AKI PO, 90.4% presented complications, whereas in the group without AKI PO they occurred only in 29.9%. Variables age, baseline MELD, baseline creatinine, creatinine in immediate postoperative (POI), AKI and the presence of ascites were statistically significant for survival. Conclusions: There is association between AKI PO and emergency surgery and, also, between AKI PO and complications after surgery. The factors related to higher occurrence were initial MELD, basal Cr, Cr POI. The patients with postoperative AKI had a higher rate of complications and higher mortality.


  • Open Access

    PROTOCOL FOR LIVER TRANSPLANTATION IN HILAR CHOLANGIOCARCINOMA

    by Lucas Ernani, Rodrigo Bronze de Martino, Wellington Andraus, Eduardo de Souza Martins Fernandes, Felipe Pedreira Tavares de Mello, Ronaldo Andrade, Leandro Savattone Pimentel, Luciana Bertocco de Paiva Haddad, Fabricio Ferreira Coelho, Paulo Herman, et al.

    Background: Hilar cholangiocarcinoma represents more than half of all cholangiocarcinoma cases, having poor prognosis and presenting a median overall survival after diagnosis of 12-24 months. In patients who have unresectable tumors with a better prognosis, the proposal to perform liver transplantation emerged for expanding the possibility of free margins by performing total hepatectomy. Aim: To provide a Brazilian protocol for liver transplantation in patients with hilar cholangiocarcinoma. Method: The protocol was carried out by two Brazilian institutions which perform a large volume of resections and liver transplantations, based on the study carried out at the Mayo Clinic. The elaboration of the protocol was conducted in four stages. Result: A protocol proposal for this disease is presented, which needs to be validated for clinical use. Conclusion: The development of a liver transplantation protocol for cholangiocarcinoma aims not only to standardize the treatment, but also enable a better assessment of the surgical results in the future.


  • Open Access

    First Successful Isolated Intestinal Transplant in a Brazilian Series

    by Wellington Andraus, Rafael Soares Pinheiro, Allana Christina Fortunato, Flavio Henrique Ferreira Galvão, Rubens Macedo Arantes, Daniel Reis Waisberg, Andre Dong Lee, Mariana Hollanda Martins da Rocha, Lucas Souto Nacif, Vinicius Rocha Santos, et al.


  • Open Access

    Coronavirus Disease 2019 in the Early Postoperative Period of Liver Transplantation: Is the Outcome Really So Positive?

    by Daniel Reis Waisberg, Edson Abdala, Lucas Souto Nacif, Liliana Ducatti, Luciana Bertocco Haddad, Rodrigo Bronze Martino, Rafael Soares Pinheiro, Rubens Macedo Arantes, Flavio Henrique Galvao, Larissa Nunes Gouveia, et al.

    We read with interest Massoumi et al.’s article(1) regarding 5 patients who developed coronavirus disease 2019 (COVID‐19) in the early postoperative period of liver transplantation (LT). None of them exhibited severe disease and they all fully recovered, suggesting that COVID‐19 in the early postoperative period of LT might not be associated with unfavorable outcomes. Here, we share our experience with 7 cases, which was not so promising.